EASL Campus

tomasz07 tomasz07 commented on ERN Rare-Liver on-demand Webinar…

2 weeks ago

ERN Rare-Liver on-demand Webinar: Alpha-1 antitrypsin deficiency: A poster child for nucleic acid therapy

Description In this ERN Rare-Liver webinar, held on 12 December 2023, Prof. Strnad and Dr Ruiz gave an exciting update to the alpha-1 antitrypsin deficiency. The presentation covered “siRNA therapy in hepatology: a1-AT deficiency”. Targeted Audience General practitioners Hepatologists Oncologists Health care professi...

0

1

Read more about ERN Rare-Liver on-demand Webinar: Alpha-1 antitrypsin deficiency: A poster child for nucleic acid therapy
Log in to post comments

tomasz07 tomasz07 • 2 weeks ago

test

Like

0 likes

Dislike 0

Reply

Comment
Christian Molina-Aguilar posted

7 months ago
Margaret Vernon commented on EASL Studio - Deciphering the dr…

8 months ago

EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention   Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehr...

0

2

Read more about EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)
Log in to post comments

Margaret Vernon • 8 months ago

Excellent discussion - very informative - thank you

Like

1 like

Dislike 0

Reply

Comment

Margaret Vernon • 8 months ago

Excellent discussion - very informative - thank you

Like

0 likes

Dislike 0

Reply

Comment
Luis Rodriguez commented on TIPS and ascites (Complete Sessi…

9 months ago
ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

10 months ago

Non-alcoholic fatty liver disease: A patient guideline

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...

2

1

ABU SALEH MD S… • 10 months ago

EASY LANGUAGE

Like

1 like

Dislike 0

Reply

Comment
ABU SALEH MD SADEQUL ISLAM commented on Liver Cancer Explained

10 months ago

Liver Cancer Explained

Liver cancer is the third leading cause of cancer-related deaths worldwide and the primary cause of death for patients with cirrhosis. Most of liver cancers are hepatocellular carcinomas, however some patients develop intrahepatic cholangiocarcinomas (ICC) or rare tumours in non-cirrhotic livers. Chronic liver diseases, alcohol c...

1

1

ABU SALEH MD S… • 10 months ago

EXCELLENT SUMMARIZE

Like

1 like

Dislike 0

Reply

Comment
ABU SALEH MD SADEQUL ISLAM commented on ILC 2021 Takeaways – Public heal…

10 months ago

ILC 2021 Takeaways – Public health

As part of the International Liver Congress (ILC) 2021, the EASL Takeaways take a look at key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective. This session, presented by Professors Maria Buti, Shira Zelber-Sagi and Antonio Craxì, explores prominent themes f...

1

1

Read more about ILC 2021 Takeaways – Public health
Log in to post comments

ABU SALEH MD S… • 10 months ago

EXCELLENT DISCUSSION

Like

1 like

Dislike 0

Reply

Comment
元春刘 posted

10 months ago
LUIZ OTAVIO Cangussu posted

10 months ago
LUIZ OTAVIO Cangussu posted

10 months ago
ABU SALEH MD SADEQUL ISLAM commented on EASL Clinical Practice Guideline…

10 months ago

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Ass...

0

1

ABU SALEH MD S… • 10 months ago

EXCELLENT

Like

0 likes

Dislike 0

Reply

Comment
Rehana Begum commented on Mycophenolate Mofetil as first l…

10 months ago
Vincenzo Mazzaferro commented on EASL Studio - Advances in system…

10 months ago

EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)

EASL Studio - Advances in systemic treatments in liver cancer   Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty)

0

1

Read more about EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)
Log in to post comments

Vincenzo Mazzaferro • 10 months ago

😊

Like

1 like

Dislike 0

Reply

Comment
mohamed abdiaziz posted

10 months ago
Rahim Khan commented on EASL Studio S6 E12: Do we care e…

11 months ago

EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

Description Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare c...

0

1

Read more about EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?
Log in to post comments

Rahim Khan • 11 months ago

Can I discuss a case and get opinion's from expert when to consider liver biopsy ?

Like

0 likes

Dislike 0

Reply

Comment
Gavin Hooper-Newton commented on Hepatitis C Point of Care Testin…

1 year ago

Hepatitis C Point of Care Testing

Created on
6 Feb 2024
by
Gavin Hooper-Newton

0

1

Read more about Hepatitis C Point of Care Testing

Gavin Hooper-Newton • 1 year ago

Please feel free to complete and share my masters research survey for informing development of a systemized community and non-regulated workforce approach to enabling HCV POCT training, testing and linking to care https://forms.gle/tAw6mpct6AnDgstq7

Like

0 likes

Dislike 0

Reply

Comment
Gavin Hooper-Newton created a topic

1 year ago

Hepatitis C Point of Care Testing

Created on
6 Feb 2024
by
Gavin Hooper-Newton

0

1

Read more about Hepatitis C Point of Care Testing
Gavin Hooper-Newton posted

1 year ago
Daniza Contreras commented on EASL Studio S5 E10: Why should d…

1 year ago

EASL Studio S5 E10: Why should diabetologists care about the liver?

Description In this episode, participants tackle the relationship between metabolic dysfunction-associated steatotic liver diseases (MASLD) and type 2 diabetes (T2D), exploring their prevalence and the potential for more aggressive outcomes. Experts weigh in on the pressing questions of whether non-invasive test thresholds shoul...

1

1

Read more about EASL Studio S5 E10: Why should diabetologists care about the liver?
Log in to post comments

Daniza Contreras • 1 year ago

Great

Like

1 like

Dislike 0

Reply

Comment
ABU SALEH MD SADEQUL ISLAM posted

1 year ago